AGTR1 and COVID-19: When Sartans are used as antihypertensive drugs, two of their targets (i.e., AT1R and PPARG-γ) are alternatively spliced and result in 22 alternatively spliced transcripts, whereas if they are repurposed for the treatment of COVID-19, they result in 12 alternatively spliced transcripts.